Daiichi Sankyo

-4.06%

include pharmaceuticals, vaccines, over-the-counter products, and medical devices. Some of their specific products and services include:
1. Pharmaceutical products: Daiichi Sankyo offers a wide range of prescription drugs for the treatment of various health conditions, including cardiovascular diseases, infectious diseases, respiratory disorders, and cancer. Some of their popular drugs include AZOR, Benicar, LIXIANA, and BEVYXXA.
2. Vaccines: The company also produces vaccines to prevent diseases like influenza, meningococcus, and chickenpox. Their vaccine portfolio includes CVI, NTRUSSIA, and FLUARIX.
3. Over-the-counter products: Daiichi Sankyo provides over-the-counter medications for minor ailments like headaches, colds, and allergies. Some of their OTC products include LIV.52, POLARAMINE, and ALLEGRA.
4. Medical devices: The company offers a range of medical devices for diagnostic and treatment purposes, including blood glucose meters, insulin pumps, and blood pressure monitors.
5. Research and development: Daiichi Sankyo invests heavily in research and development to discover and develop innovative treatments for patients. Their research covers various therapeutic areas such as oncology, infectious diseases, and cardiovascular diseases.
6. Clinical trial services: The company also offers services related to clinical trials, including trial design, data management, and statistical analysis. This helps them to gather essential data for the development of new drugs and treatments.
7. Collaboration and partnerships: Daiichi Sankyo collaborates with other pharmaceutical companies, academic institutions, and research organizations to accelerate the discovery and development of new treatments. Some of their collaborations include partnerships with Merck, AstraZeneca, and the University of Tokyo.
8. Patient support programs: The company provides support programs for patients to help them access medication and manage their diseases effectively. These programs offer financial assistance, educational resources, and emotional support for patients and their families.
9. Digital health solutions: Daiichi Sankyo is investing in digital health technologies to improve patient outcomes and advance healthcare. They have initiatives in telemedicine, digital therapeutics, and data-driven healthcare solutions.
10. Commitment to sustainability: Daiichi Sankyo is committed to sustainability and social responsibility. They have set goals to reduce their environmental impact, promote diversity and inclusion, and improve access to healthcare in underserved communities.